Legacy VC Radius Ventures wound down operations as of December 2024, signaling an opportunity to engage successor funds, alumni networks, and leadership spinoffs (JSD Capital LLC and Upsher Management Company) that may hold legacy portfolio interests or be sourcing new healthcare investments.

Portfolio Exits Past investments include companies with notable exits or IPOs across health IT, diagnostics, and medical devices. Targeting Portfolio successors and management teams could yield co-investment opportunities, M&A leads, or advisory roles leveraging Radius’s proven track record.

Healthcare Focus The firm’s historical concentration in life sciences, medical technology, diagnostics, and healthcare IT suggests a strong appetite for early to growth-stage health tech ventures; identify opportunities to connect with former associates directing new health care fund strategies or partnerships.

Industry Networking Key personnel now active in related ventures (JSD Capital, Upsher Management) offer warm introductions to healthcare founders, syndicate partners, and limited partners seeking robust life sciences investment opportunities.

Current Footprint Radius’s legacy landing page and public profile indicate ongoing ecosystem presence; sales teams can leverage this to propose advisory, fund-of-funds, or niche investment vehicles that align with Radius’s historical thesis and alumni activity.